






Clinical outcomes in adolescents with perinatally acquired HIV (PaH) transitioning from 
paediatric to adult care in a large regional HIV clinic in London 
 
 
Abstract:  (Your abstract must use Normal style and must fit into the box. Do not enter author details) 
Introduction: 
We assessed outcomes in PaH adolescents transitioning from paediatric to adult care 
within a regional HIV clinic 
 
Methods: 
Retrospective case-note review 10/02/04-31/12/15. Data collected: demographics, CDC 
stage, viral loads (VL), CD4 counts, antiretroviral therapy (ART), resistance and loss to 
follow up; using a standardised database. Pre- and post-transition outcomes were 
compared using paired T-tests for means and McNemar’s Exact tests for proportions. 
 
Results: 
57 patients; 29(51%) male, 34(60%) born outside UK, 51(89%) black African. Median age 
at diagnosis 3 years [range 0–18]; at transition 18 years [15-20]. Median time since 
transition 5 years [1 month–13 years]. At transition CDC B 27/57(47%), CDC C 
18/57(32%), post transition 28/57(49%), 20/57(35%), respectively, including one suicide.  
Of those with ≥2 years data post-transition, 31/48(65%) had two consecutive VL>40c/mL 
or one VL>10,000c/mL in the 2 years pre-transition, compared to 22/48(46%) post-
transition (p=0.035). Mean CD4 count 12 months pre/post-transition 520 c/mm3, 500 
c/mm3, respectively (p=0.4). At transition 52/57(91%) on ART (vs. 55(96%) at last visit, 
p=0.1), 10/46(22%) 1st line (5/55(9%) last visit), median duration of ART 7 years [0–18].  
Resistance:  18/46(39%) nil, 13/46(28%) ≥1, 13/46(28%) ≥2, 1/46(2%) ≥3 drug classes. 4 
patients were lost to follow-up (LTFU), all returning within 5 years [1-5]. 
 
Discussion: 
There was no difference in mean CD4 pre or post-transition, but the proportion who were 
suppressed improved post-transition.  CDC stage progressed in 3 adolescents. All patients 
had options for suppressive ART although few were on 1st line. There was no long-term 
LTFU. 
  
